AXA Framlington Managed Balanced Fund Z GBP Inc
|AXA Framlington Emerg Markets Acc||2.55 %|
|GlaxoSmithKline PLC||1.93 %|
|AstraZeneca PLC||1.86 %|
|Japan (Government Of) 0.1%||1.78 %|
|United Kingdom of Great Britain and Northern Ireland 0.88%||1.20 %|
|United Kingdom of Great Britain and Northern Ireland 2%||1.16 %|
|Reckitt Benckiser Group PLC||1.08 %|
|Royal Dutch Shell PLC B||1.08 %|
|Prudential PLC||1.05 %|
|Rentokil Initial PLC||1.02 %|
|United Kingdom||42.47 %|
|United States||23.45 %|
|Europe - ex Euro||6.76 %|
|Financial Services||18.07 %|
|Consumer Cyclical||11.61 %|
|Consumer Defensive||8.72 %|
|Communication Services||5.03 %|
Jamie joined AXA Framlington in November 2006 and is a fund manager covering UK Growth. Prior to a career in asset management, Jamie worked for Barclays plc for 8 years as a senior corporate advances analyst. He has managed both Institutional and Retail mandates (including Investment Trusts) for the past 7 years. In 1995 Jamie joined the group which subsequently evolved through numerous mergers into the current F&C Asset Management plc.
Nick Hayes joined New Star in 2002 and has developed his fund management skills alongside his highly-rated fixed income colleagues, James Gledhill and Philip Roantree. Prior to joining New Star, Nick worked at WPP Group. Nick holds a BA in French and Spanish from Trinity College, Dublin.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.